Our weight loss programs combine provider-directed care, individualized treatment plans, and ongoing clinical support
Industry reporting from Clinical Trials Arena in December 2025 flagged seven additional Phase 3 readouts expected during 2026, which is consistent with a Q4 2026 or Q1 2027 submission target
Bij een BMI boven de 35 is een maagverkleining vaak geschikter
You need a smart plan, a coach who adjusts with you, and a place to start that isn't going to overwhelm you on day one
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza), are increasingly prescribed for type 2 diabetes management and weight loss in the UK
Add notes to each calculation for better organisation and reference